Learn more
Log in
0 followers
Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins.
Industries
Headquarters
Stage
Employees
Links
Scott Clarke
17 members
9 members
8 members
4 members
UpGuard
3 followers
Landmark Bio
1 follower
Satisfi Labs
2 followers
Black Diamond Therapeutics
VitroLabs
Discover companies